CXCL13 and plasma cell myeloma: Zhang found that mesenchymal stem cells (MSCs) could secrete a large amount of CXCL13 in the bone marrow microenvironment of multiple myeloma and promote the proliferation, metastasis and drug resistance of myeloma cells through a CXCL13-mediated signaling pathway32.